DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML
SANDOZ CANADA INCORPORATED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML in Canada?
Yes. DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML has an active shortage reported to Health Canada (last updated September 8, 2026).
Why is DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML not available?
The reason the manufacturer reported: Requirements related to complying with good manufacturing practices.
When will DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML be available again?
The estimated resolution date (September 18, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
DEXAMETHASONE SODIUM PHOSPHATE INJECTION SDZ
SANDOZ CANADA INCORPORATED
Other Products
PMS-DEXAMETHASONE SOD PHOSPHATE INJ 4MG/ML
PHARMASCIENCE INC
PMS-DEXAMETHASONE SOD PHOSPHATE INJ 10MG/ML
PHARMASCIENCE INC
PHL-DEXAMETHASONE
PHARMEL INC
DEXAMETHASONE
JUNO PHARMACEUTICALS CORP.
DEXAMETHASONE UNIDOSE
JUNO PHARMACEUTICALS CORP.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-09-18
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
00664227
Strength
4MG
Dosage Form
SOLUTION
Route
INTRAVENOUS INTRASYNOVIAL INTRAMUSCULAR
Active Ingredient
DEXAMETHASONE PHOSPHATE
Tier
Tier 3 — Critical
Last Updated
2026-09-08
Reason for Shortage
Requirements related to complying with good manufacturing practices.
Past Reports for This Drug
DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495910
DIN 02495937
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759